DMAAR

Drugs Made In America Acquisition Corp Rights
DMAAR

24 hedge funds and large institutions have $2.22M invested in Drugs Made In America Acquisition Corp Rights in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $
Holders
24
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$250K
2
+$81.5K
3
+$73.3K
4
WCMNY
Westchester Capital Management (New York)
New York
+$64.3K
5
SSA
Schonfeld Strategic Advisors
New York
+$27.6K

Top Sellers

1
-$2.4K
2
-$1.56K
3
-$257
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$234K
2
$228K
3
$225K
4
$180K
5
$156K
6
$107K
7
$106K
8
$106K
9
$102K
10
$80.8K
11
$79.2K
12
$72.2K
13
$68.5K
14
$68.5K
15
$62.5K
16
$62.5K
17
$60.1K
18
$60.1K
19
$49.8K
20
$48.1K
21
$21K
22
$18K
23
$12.5K
24
$8.77K
25
–